[Use of ceftriaxone in the prevention of postoperative purulent complications after surgery on the stomach and small intestine].
Ceftriaxone was administered intravenously in a single dose of 1.0 g 15 minutes prior to surgical intervention for peptic ulcer and gastric or duodenum tumor in 31 patients at the age of 33 to 74 years. In all the patients primary adhesion of the surgical wound was recorded. No signs of local or general infection were observed. The indices of the total blood count, urinalysis and blood biochemical analysis came to normal by the 5th or the 7th day of the postoperative period. The levels of ceftriaxone in the blood, urine, stomach wall, small intestine tissues and subcutaneous fat were evaluated. The indices of the cellular and humoral immunity in the pre- and postoperative periods in the patients prophylactically treated with ceftriaxone were analyzed.
Iakovlev
V P
VP
A.V. Vishnevsky Institute of Surgery, Russian Academy of Medical Sciences, Moscow.
Khlebnikov
E P
EP
Kubyshkin
V A
VA
Elagina
L V
LV
Budaev
K D
KD
Izotova
G N
GN
Korniak
V S
VS
Tsvirkun
V V
VV
Vukolov
V V
VV
D000328:Adult; D000368:Aged; D000917:Antibody Formation; D002443:Ceftriaxone / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use*; D004379:Duodenal Neoplasms / Q000601:surgery*; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000601:surgery*; D011183:Postoperative Complications / Q000517:prevention & control*; D012307:Risk Factors; D013276:Stomach Ulcer / Q000601:surgery*
D002511:Cephalosporins; D002443:Ceftriaxone